Go to the
original guidance.

Sources and limits

Checked October 5, 2026. Federal sources provide general guidance; provider pages describe advertised terms. These sources do not assess an individual patient's situation.

1. MedlinePlus — tirzepatide injection precautionsFederal patient drug information
2. HRSA Poison Help — calling for expert guidanceFederal poison-response resource
3. HRSA Poison Help — what you can doFederal emergency preparedness guidance
4. FDA BeSafeRx — online pharmacy informationPharmacy verification and reporting resources
5. CoreAge Rx — official treatment pagesProvider offer
6. CoreAge Rx — tirzepatide offerProvider offer
7. CoreAge Rx Help Center — Pricing & PlansProvider billing terms
8. SuperHealthy Rx — current GLP-1 offerProvider offer
9. Likeness Rx — GLP-1 plans and billingProvider offer
10. Ro Body — membership and medication costsProvider offer
11. WeightWatchers — Med+ membership and medicationProvider offer
12. LillyDirect — pharmacy access and independent care optionsManufacturer access program
13. FDA — concerns with unapproved GLP-1 drugsRegulator guidance
14. FDA — compounding questions and answersRegulator guidance
15. FDA — dosing errors with compounded injectable semaglutideSafety alert, July 2024
16. NIDDK — prescription medications for overweight and obesityFederal patient education